Reaction of octafluorotoluene, 3,5-dichlorotrifluoropyridine, 3-chlorotetrafluoro-yridine and tetrafluoropyrimidine with alkali-metal oximates

Treatment of octafluorotoluene (2) with approximately one-molar equivalents of the oximates R¹R²C = NO~ M⁺ (R¹ = R²=Me;R¹ = R² = Ph; R¹ = Me, R² = Ph;M = Na) (6a-c) in diethyl ether gives 4-(R¹R²C = NO)C₆F₄CF₃ (7a-c) as the only isolated products. Corresponding reaction of 3,5-dichlorotrifluoropyridine (3) with the oximates 6a-c affords 4-and 2-(R¹R²C = NO)C5F₂C12N (8a-c) and (9a-c), respectively (4-/2ratios at −35 °C: 65:35; 30:70; 12:88) ; the lithium oximates (R¹ = R² =Ph ; R¹ = Me, R² = Ph; M = Li) (6d) and (6e) give comparable results. With 3-chlorotetrafluoropyridine (4), treatment with sodium oximate 6c gives 4-(PhCMe = NO)-3-ClC₅F₃N (10) and 2-(PhCMe = NO)-5ClC₅F₃N (11) (ratio 44:56 at −35 °C). Such competition between S_NAr attack of these alkali-metal oximates at the C-4 and C-2 positions of chlorofluoropyridines 3 and 4 can be rationalized by invoking chelation of an alkali-metal cation with ring nitrogen in the transition state leading to formation of an orthio-quinonoidal σ-complex. Exclusive initial attack at the C-4 ring site appears to occur in the reaction of tetrafluoropyrimidine (5) with oximates 6a and 6c to afford 4-(MeC = NO)C₄F₃N₂ (12a) and 4-(PhCMe=NO)C₄F₃NN₂ (12b), respectively; Some further attack on product 12b by oximate 6c at the C-6 site takes place to give the disubstituted derivative 4,6-(PhCMe=NO)₂C₄F₂N₂ (13).     

The Synthesis And Crystal Structure Of 3-[5-Methyl-1-(4-Methylphenyl)-1,2,3-Triazol-4-yl]-s-Triazolo[3,4-b]-1,3,4-Thiadiazole

Likewise the 1,3,4-thiadiazole nucleus which incorporates an N-C-S linkage exhibits a large number of biological activities^[1]. The fused 1,3,4-triazolo[3,4-b]-1,3,4-thiadiazoles derivatives show various biological effects, such as antifungal^[2], antibacterial, hypotensive and CNS depressant activities^[3]. The novel 3-[5-methyl-1-(4-methylphenyl)-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole 6 have been synthesized by the condensation of 4-amino-5-mercapto-3-[5-methyl-1-(4-methylphenyl)-1,2,3-triazol-4-yl]-s-triazole 5 with formic acid in the presence of phosphorus oxychloride. The compound 5 was prepared from 4 that was prepared from 1 throng 2 and 3. Recently, we obtained the crystal structure of the novel compound 3-[5-methyl-1-(4-methylphenyl)-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole, C₁₄H₁₂Cl₃N₇S, Mr=416.72, Crystallizes in the triclinic space group with unit cell parameters a=9.049(2), b=10.486(3), c=10.843(2)Å, α=116.79(2), β=93.83(2), γ-100.64(3)°. V=889.3(4)ų, Z=1, Dx-0.778 Mgm^-3. The final R was 0.0535.     

芳香查尔酮衍生物的合成、理论计算及三阶非线性光学性质

合成了2种新的具有潜在应用价值的非线性光学(NLO)有机材料芳香查尔酮衍生物1-(呋喃-2-基)-3-(4-甲氧基苯基)丙烯酮(1)和1-(噻吩-2-基)-3-(4-甲氧基苯基)丙烯酮(2),并对其进行了NMR、IR和HR-MS结构表征。 采用4f相位相干成像技术测定了化合物1和2的三阶NLO性质并确定了相关参数:脉冲宽度4 nm,激光波长440 nm,化合物1:非线性吸收系数β=5.5×10^-10 m/W,非线性折射系数n₂=-2.1×10^-17 m²/W,三阶非线性极化率χ⁽³⁾=1.58×10^-11 esu;化合物2:β=-2.4×10^-10 m/W,n₂=0.3×10^-17 m²/W,χ⁽³⁾=0.50×10^-11 esu;并测定了紫外光谱和DSC曲线。 采用密度泛函方法计算了化合物1和2的轨道能量和极化率,结果表明电子转移能在分子内部进行,说明比较易于极化,展示了良好的非线性光学性质。     

2-(Phenyltelluromethyl)tetrahydrofuran (L) and 2-(2-{4-methoxyphenyl}telluroethyl)-1,3- dioxolane (L) and their palladium(II) and platinum(II) complexes

The nucleophile [ArTe⁻] generated in situ borohydride solution of Ar₂Te₂, reacts with 2-(chloromethyl) tetrahydrofuran and 2-(2-bromoethyl)-1,3-dioxolane resulting in L¹ and L², respectively. The complexes of palladium(II) and platinum(II) with L¹/L² having stoichiometries [MCl₂·L₂], [ML₂](ClO₄)₂, [(DPPE)ML₂](ClO)₄)₂, [(PPh₃)₂ML₂](ClO₄)₂ and [(phen)ML₂](ClO₄)₂ (where L = L¹/L² DPPE = Ph₂PC H₂CH₂PPh₂, PHEN = 1,10-phenanthroline and M = Pd/Pt) have been synthesized. IR, ¹H, ¹²⁵Te{¹H} and ³¹P{¹H} NMR and UV-vis spectral data of these species in conjunction with their molar conductance and molecular weight data have been used to authenticate the new species. In all complexes (1–20) the ligands L¹ and L² are coordinated through tellurium and in the complexes of formula [ML₂](ClO₄)₂ (M = Pd, Pt) the ligand is bidentate with the oxygen atom used in complexation. In solution, complexes PtCl₂L₂ exist as a mixture of cis and trans isomers whereas only the trans isomer was observed for the palladium analogues. The [(phen)PdL₂](ClO₄)₂(Q) quenches ¹O₂ readily. The plot of log [Q] vs time is linear. Mechanism compatible with the experimental observations is proposed.     

Synthesis and liquid crystal properties of dinuclear cyclopalladated 5-alkyl-2-(4'-alkoxyphenyl)pyrimidine and 3-(4'-alkoxyphenyl)-6-alkoxypyridazine complexes

The dinuclear cyclopalladated complexes [Pd(L₁ or L₂)(µ-X)]₂ (HL₁=5-alkyl-2-(4'-alkoxyphenyl)pyrimidine, HL₂=3-(4'-alkoxyphenyl)-6-alkoxypyridazine, X=Cl^-, CH₂ClCOO^-, CH₂BrCOO^-, CH₃CHBrCOO^-, CH₂BrCH₂COO^-, CH₃COO^-) have been synthesized and characterized; their mesogenic properities were determined by DSC and polarizing microscopy. The effect of the bulk and the polarity of the bridging ligands on their mesogenic properties is discussed. The effect of the length of the alkyl chains on the mesogenic properties of these organometallic complexes has also been investigated.     

Synthesis and Structure of N-(E)-Enoyl(-)-bornane-10,2-sultams

Ｃｈｉｒａｌｉｔｙｄｕｅｔｏａｌｋｙｌｂｒａｎｃｈｉｎｇｉｓａｂｕｎｄａｎｔａｍｏｎｇｓｅｖｅｒａｌｎａｔｕｒａｌｌｙｏｃｃｕｒｒｉｎｇｓｅｃｏｎｄａｒｙｍｅｔａｂｏｌｉｔｅｓ .Ｔｈｉｓｓｔｒｕｃｔｕｒｅｆｅａｔｕｒｅｉｓｐａｒｔｉｃｕｌａｒｌｙｐｒｅｄｏｍｉｎａｎｔａｍｏｎｇｉｎｓｅｃｔｐｈｅｒｏｍｏｎｅｓ[1] ,ｍａｎｙｏｆｗｈｉｃｈａｒｅｏｆｅｃｏｎｏｍｉｃｓｉｇｎｉｆｉｃａｎｃｅ .Ａｓａｒｅｓｕｌｔ,ａｃｏｎｓｉｄｅｒａｂｌｅｅｆｆｏｒｔｈａｓｂｅｅｎｍａｄｅｔｏｓｙｎｔｈｅｓｉｚｅｔｈｅｍ…     

含功能取代基的C2Mo2簇合物的合成与晶体结构测定

利用苯乙炔或丙炔醇与[Mo(CO)₂(η⁵-C₅H₄R¹)]₂[R¹＝C(O)Me,C(O)OEt,C(O)Ph]的反应合成了6个新的炔烃配位的双钼化合物[Mo(CO)₂(η⁵-C₅H₄R¹)]₂(μ-η²,η²-(CH=CR²)[R¹＝C(O)Me,R²＝Ph,1;R¹＝C(O)OEt,R²＝Ph,2;R¹＝C(O)Ph,R²＝Ph,3;R¹＝C(O)Me,R²＝CH₂OH,4;R¹＝C(O)OEt,R²＝CH₂OH,5;R¹＝C(O)Ph,R²＝CH₂OH,6],并对这些化合物进行了C/H元素分析,IR,¹HNMR等表征.晶体X射线衍射分析结果表明,化合物1属单斜晶系,P2₁(＃4)空间群,晶胞参数a＝0.7671(2)um,b＝0.8365(2)nm,c＝1.8308(3)nm,β＝98.34(1)°,V＝1.1623(5)um³,Z＝2,D_c＝1.772g·cm^-3,F(000)＝616,R＝0.041,R_w＝0.045.     

The First Gallium Borophosphate NaGa[BP2O7(OH)3]:Synthesis and Crystal Structure Characterization

Borophosphates, as potential microporous materials, have drawn much attention in recent years and show rich chemistry^[1-3]. Although many compounds with transition metals have been reported, compounds with the p-block main group elements participating in the framework are rare^[4] The title compound has been synthesized by mild hydrothermal methods and crystal structure characterized by X-ray single crystal methods. Crystallographic data:monoclinic,C2/c (No. 15), a=10.408(3), b=8.094(2),c=9.099(2) Å, β=116.64(2), Z=4, R=0.0246,Rw=0.0676. The crystal structure contains isolated anions[(OH)O₂P_1/2-O_1/2B(OH)₂O_1/2-O_1/2PO₃]^4-. Geometrically, four GaO₆ groups with four PO₄ groups form an eight-member ring by sharing comers resulting to a two dimensional layer in be plane. The layers are joined by BO₄ group through comer sharing with GaO₆ and PO₄ and result to a three dimensional network structure. A 350pm x 600pm open channel along c-axis can be seen (figure below) and occupied by Na cations.     

修饰NADH模拟物的金属-有机三元环光催化制氢

将含有不同还原型烟酰烟腺嘌呤二核苷酸(NADH)活性中心模拟物的有机配体H2L1和H2L2与钴离子配位自组装获得2例具有氧化还原活性且带有正电荷的金属-有机大环Co-L1和Co-L2.选择阴离子型钌基光敏剂[Ru(dcbpy)3]4-(dcbpy=2,2'-联吡啶-4,4'-二羧酸)作为光敏中心,金属-有机大环结构作为...     

Metal complexes of sterically hindered pyrzolylpyridines. The single crystal X-ray structure of [Cu(L)2]BF4 (L = 1-{pyrid-2-yl}-3-{2′,5′-dimethoxyphenyl}pyrazole)

Reaction of potassium 3{5}-(3′,4′-dimethoxyphenyl)pyrazolide with 2-bromopyridine in diglyme at 130°C for 3 days followed by an aqueous quench, affords 1-{pyrid-2-yl}-3-{3′,4′-dimethoxyphenyl}pyrazole (L²) in 69% yield after recrystallization from hot hexanes. Complexation of [Cu(NCMe)₄]BF₄ by 2 molar equivalents of 1-{pyrid-2-yl}-3-{2′,5′-dimethoxyphenyl}pyrazole (L¹) or L² in MeCN at room temperature, followed by concentration and crystallisation with Et₂O, gives [Cu(L)₂]BF₄ L = L¹, L²) in good yields. Treatment of AgBF₄ with L¹ or L² in MeNO₂ similarly gives [Ag(L)₂]BF₄ L = L¹, L²); reaction of AfBF₄ with L² in MeCN gives a product of stoichiometry [Ag(L²)(NCMe)]BF₄. The ¹H NMR spectra of the [M(L)₂]BF₄ complexes show peaks arising from a single coordinated environment. The single crystal X-ray structure of [Cu(L¹)₂]BF₄ shows a tetrahedral complex cation with Cu---N = 2.011(8), 2.036(8), 2.039(8), 2.110(8) Å. The Cu^I centre is close to tetrahedral, the dihedral angle between the least-squares planes formed by the Cu atom and the N donor atoms of the two ligands being 88.3(3)°. Complexation of hydrated Cu(BF₄)₂ by L² in MeCN at room temperature yields [Cu(L₂)₂](BF₄)₂. The cyclic voltammograms of the three Ag^I complexes in MeCN/0.1 M Bu₄ⁿ NPF₆ are suggestive of extensive ligand dissociation in this solvent.     

铜(Ⅱ)与2-羰基丙酸水杨酰腙配合物的合成、晶体结构和抑菌活性

以2-羰基丙酸水杨酰腙作为配体与五水硫酸铜进行反应,制得配合物Cu(C₁₀H₈N₂O₄)(H₂O)₂(1)和Cu(C₁₀H₈N₂O₄)(CH₃OH)(H₂O)(2)(C₁₀H₈N₂O₄^2-为2-羰基丙酸水杨酰腙负离子),测试了配合物2的单晶结构.该单晶为墨绿色,属三斜晶系,P1空间群.晶胞参数a=0.7538(2)nm,b=1.1431(2)nm,c=0.7500(2)nm,α=93.26(2)^o,β=94.46(2)^o,γ=94.39(2)^o,V=0.6411(2)nm₃,μ=1.731mm^-1,Z=2,D_c=1.792g/cm³,F(000)=342.00,R=0.035,wR=0.048,GOF=1.78.在配合物2内,2-羰基丙酸水杨酰腙负离子中的2个氧原子和1个氮原子、甲醇中的氧原子以及配位水中的氧原子与铜原子配位,形成四方锥结构,其中来自甲醇的配位氧原子位于锥顶;此晶体为外消旋化合物,晶体中存在对映异构体,两者通过氢键连接,形成二聚体,成对出现在晶胞中.根据元素分析、红外和紫外光谱推测配合物1与2的结构相似;抑菌试验结果表明,配合物1对辣椒疫霉菌和烟草赤星菌分别有100%和66.02%的抑制作用.     

Kinetics of formation of intermediates in silver ion assisted aquations

There is kinetic evidence of the formation of [Co(NH₃)₅NCSAg₃]⁵⁺ in the interaction of [Co(NH₃]⁵NCS]²⁺ with Ag⁺ in aqueous solution, with pseudo-first-order formation rate constant k = 0.158 s⁻¹ for the forward reaction in the following equation at 25°C and [Ag⁺] in the range of 1.23–5.0 × 10⁻² mol dm⁻³ and 0.10 ionic strength (NaClO₄):

Full-size image

Additionally, the formation constant, β₂, for [Co(NH₃)₅NCSAg₂]⁴⁺ has been determined to be log β₂ = 4.717. For the [Rh(NH₃)₅I]²⁺-Ag⁺ reaction there is evidence of an outer-sphere interaction with rate constants of k₂ = 670 dm³ mol⁻¹ s⁻¹ at 25°C and 0.10 ionic strength. This outer-sphere species undergoes further reaction to give the silver ion containing intermediates of the aquation reactions.     

氮杂大环双核铜锌金属配合物的合成结构及溶液中配位稳定性研究

在合成模型化合物之前 ,有必要先了解合成的大环配体在溶液中与金属离子的配位行为及其稳定性 ,以便选择不同结构的大环配体和控制反应的 p H值合成出结构和催化性能较好的模型化合物 [1～ 3] .本文报道了大环配体与 Cu( )和 Zn( )形成的配合物 ,对其结构和溶液中的配位稳定性进行了研究 .1　实验部分1 .1　试剂与仪器配体 L以 2 ,6-吡啶二甲醛和二乙烯三胺为原料 ,按文献 [4]报道的方法经 2 + 2合成得到 .其纯度经元素分析、红外光谱、核磁共振氢谱和质谱鉴定 .其它试剂均为分析纯 . p H滴定采用二次蒸馏水 .Perkin- Elmer 2 4 0型元…     

2-(N-环己胺)-6-三氟甲氧基苯并噻唑的合成及其晶体结构

以利鲁唑为原料,与硫酸肼经回流反应制得2-肼基-6-三氟甲氧基苯并噻唑(2); 2经氯化亚砜氯代制得2-氯-6-三氟甲氧基苯并噻唑(3);3与环己胺经取代反应合成了新化合物2-(N-环己胺)-6-三氟甲氧基苯并噻唑(4),其结构经¹H NMR, IR,元素分析和X-射线单晶衍射表征。4 (CCDC：1 440 686)属三斜晶系,P-1空间群,晶胞参数a=10.617(3) , b=13.607(4) , c=16.619(5) , V=2 201.8 ³, Dc=1.422 g·cm^-3, Z=6, R₁=0.082 0, wR₂=0.235 1。     

氮氧杂链型配体合成与Cu(Ⅱ)和Zn(Ⅱ)配位性质研究

合成了4种氮氧杂链型配体N,N'-二-(2-羟乙基)-乙二胺(L¹)、N-(2-羟基苄基)-丙醇胺(HL²)、N-(2-羟乙基)-N'-(2-羟基苄基)-乙二胺(HL³)和N-(2-羟乙基)-二乙三胺-(L⁴),通过元素分析、IR和¹H NMR等手段表征了其结构,用pH电位滴定法在25℃、I=0.10(KNO₃)条件下,测定了L¹和HL²与Cu(Ⅱ)离子以及HL³和L⁴与Zn(Ⅱ)离子配位平衡常数.结果表明:L¹和HL²与Cu(Ⅱ)离子配位时,均可生成四配位配合物,其中第三配位点醇羟基配位较强,其质子离解常数pK_a1分别为7.28和7.32;第四配位点是第2个醇羟基或1个水分子配位,其pK_a2分别为9.33和9.04;HL³和L⁴与Zn(Ⅱ)均可生成五配位配合物,第四配位点均为醇羟基,其离解常数pK_a1分别为7.76和7.96,第五配位点均为H₂O,其pK_a2分别为9.47和9.57.从上述热力学结果可见,配合物在中性pH值范围能生成亲核试剂Cu(Ⅱ)…^-OR或Zn(Ⅱ)…^-OR,而且均具备双重催化酯类底物水解的条件.     

Synthesis and magnetism of the first tetranuclear copper(II)–iron(III) complexes of macrocyclic oxamides

Four novel tetranuclear macrocyclic complexes of the formula [(CuLⁱ)₃Fe](ClO₄)₃·3H₂O (i=1–4, Lⁱ are the dianions of the [14]N₄ and [15]N₄ macrocyclic oxamides, namely 2,3-dioxo-5,6:13,14-dibenzo-7,12-bis(ethoxycarbonyl)-1,4,8,11-tetraazacyclotetradeca-7,11-diene, 2,3-dioxo-5,6:13,14-dibenzo-9-methyl-7,12-bis(ethoxycarbonyl)-1,4,8,11-tetraazacyclotetradeca-7,11-diene and 2,3-dioxo-5,6:14,15-dibenzo-7,13-bis(ethoxycarbonyl)-1,4,8,12-tetraazacyclotetradeca-7,12-diene] have been prepared and characterized. These complexes are the first examples of oxamido-bridged Cu(II)–Fe(III) heterometallic species. Cryomagnetic studies on [(CuL¹)₃Fe](ClO₄)₃·3H₂O (1) and [(CuL³)₃Fe](ClO₄)₃·3H₂O (3) (77–300 K) revealed that the Cu(II) and Fe(III) ions interact antiferromagnetically through the oxamido bridge, with the exchange integral J=−30.8 cm⁻¹ for 1 and J=−28.7 cm⁻¹ for 3 based on . The interaction parameters have been compared with that of the related [Cu₃Mn] compound.     

新型桥联双四面体簇合物的合成与表征

利用(μ₃-CCO₂Et)Co₃(CO)₉与单阴离子试剂[Mo(CO)₃(η⁵-C₅H₄R)]-[R=H,C(O)Me]的反应合成了2个新的含CCo₂Mo骨架的簇合物(μ₃-CCO₂Et)Co₂Mo(CO)₈(η⁵-C₅H₄R)[R=H(1);R=C(O)Me(2)],进而用其与双阴离子试剂{-M(CO)₃[η⁵-C₅H₄C(O)]}₂-1,4-C₆H₄[M=Mo,W]反应合成了4个双四面体簇合物{(μ₃-CCO₂Et)CoMoM(CO)₇(η⁵-C₅H₄R)[η⁵-C₅H₄C(O)]}₂-1,4-C₆H₄[M=Mo,R=H(3);M=Mo,R=C(O)Me(4);M=W,R=H(5);M=W,R=C(O)Me(6)].这6个化合物的C和H元素分析,IR,¹HNMR等表征都与其结构一致.晶体X射线衍射分析表明,化合物2属单斜晶系,C₂/c空间群,晶胞参数a=1.1264(3)nm,b=1.1879(3)nm,c=3.3565(10)nm,β=93.320(5)°,V=4.484(2)nm₃,Z=8,D_c=1.867g·cm^-3,F(000)=2480,R=0.0369,wR=0.1150.     

4－硝基邻苯二甲酸根桥联双核钴(Ⅱ)配合物的合成、磁性及抗癌活性

研究桥联多核配合物的磁性不仅有助于了解桥联多核配合物在生物体内所起的各种生物功能,而且可为分子铁磁体的设计和合成提供信息.某些过渡金属配合物已显示了体外抗艾滋病和抗癌活性,有关桥联多核配合物在这方面的研究甚少.     

新型不对称双席夫碱化合物的合成及其晶体结构

采用“一锅法”,小分子NH₃和水杨醛分别与2-氨甲基吡啶和4-氨甲基吡啶经缩合反应合成了两种新型的不对称双席夫碱化合物--2-{1,2-二［(E)-2-羟基苯亚甲氨基］-2-(2-吡啶基)乙基}苯酚(2a)和2-{1,2-二［(E)-2-羟基苯亚甲氨基］-2-(4-吡啶基)乙基}苯酚(2b),其结构经¹H NMR, ¹³C NMR, IR和X-射线单晶衍射(2b)表征。2b(CCDC： 1 423 247)属单斜晶系,P2(1)/n空间群,晶胞参数a=10.764(3) , b=9.725(2) , c=21.934(5) , β=93.291(9) °, V=2 292.2(9) ³, Dc=1.268 mg·cm^-3, Z=4, F(000)=920, μ=0.084 mm^-1。     

柄型金属有机化合物(Ⅰ)──硅桥联二(1-茚基)和四氢茚基钛化合物的合成及结构

通过1,3-二(1-茚基)四甲基二硅氧烷的双锂盐与TiCl₄·2THF反应制得硅桥联二(1-茚基)钛化合物(Me₂SiOSiMe₂)[Ind]₂TiCl₂(1),对其催化氢化得到相应的四氢茚基化合物(Me₂SiOSiMe₂)[IndH₄]₂TiCl₂(2).对化合物1和2的单晶进行了X射线衍射结构分析,它们的晶体都属单斜晶系,P2₁/n空间群.